Neurophth Therapeutics raised $95M Series C venture round, led by Hubei KTLC.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
Hubei KTLCLEAD | Venture Capital | — |
| Private | — |
WuhanLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private Equity | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$217M
Top Valuation
-
Neurophth Therapeutics raised $95M in a Series C round.
The round was announced on 08/11/23.
The round was led by Hubei KTLC, Wuhan, Wuhan Hi-Tech Holding Group, Wuhan Optical Valley Financial Holding Group, Yangtze River-CMB International Industry Fund.